European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dime- thylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Risk assessment: 4F-MDMB-BICA)
331kB |
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on 4F-MDMB-BICA. The report is intended for policymakers and decision-makers in the institutions of the EU.
Table of contents
- Statement regarding the United Kingdom
- Contents
- Introduction
- Background
- Chemical and physical properties and the methods and precursors used for manufacture
- Pharmacological and toxicological properties
- Health risks
- Social risks
- Extent and patterns of use, availability and potential for diffusion
- Commercial and industrial uses, the extent of such use and its use for scientific research and developmental purposes
- Other relevant information
- Conclusion
Repository Staff Only: item control page